Tesamorelin / IPA Blend is a dual-peptide blend containing tesamorelin and ipamorelin intended for controlled laboratory work. It is studied in experimental systems involving GHRH- and ghrelin-receptor signaling within metabolic and GH-axis models. Descriptions of research pathways do not establish safety, effectiveness, or suitability for human or veterinary use.
Research areas include:
• Tesamorelin-related GHRH signaling
• Ipamorelin-related GHS-R1a signaling
• GH/IGF-1 and metabolic biomarker models
• Co-formulation compatibility and stability testing
Research limitations and safety:
• Blend names and ratios are not standardized. Every formulation requires explicit ingredient amounts plus independent identity, purity, compatibility, and stability verification.
• No dosing, administration, or therapeutic-use guidance is provided.
being sold for research only.





Reviews
There are no reviews yet.